Are China’s Vaccines Ready For The World?
This article was originally published in PharmAsia News
Executive Summary
With WHO approval in hand, China’s vaccine industry looks to take the next step into global markets.
You may also be interested in...
More Barriers To Entry For M&A In China? Novartis Case Provides Some Clarity
HONG KONG - Much awaited regulations on how China will review inbound mergers and acquisitions in light of national security and competition suggest long waits for pending and future deals and new barriers to entry, say some business groups
Beijing's SL Pharma and Canada's PnuVax Form Vaccine, Antibody JV
SHANGHAI - Beijing's SL Pharmaceutical announced it will invest CAD $20 million to form a joint venture in Ontario, Canada with Canadian partner PnuVax Incorporated.
China's State FDA Gets WHO Nod For Vaccine Regulatory System; Opens Global Market For Chinese Vaccine Makers
SHANGHAI - China's State FDA now complies with international standards for vaccine regulation and Chinese vaccine makers are eligible to apply for World Health Organization prequalification of vaccine products, WHO announced March 1, the same day that China implemented its newly revised good manufacturing practices (GMP) guidelines